The article says:
"With the funding of clinical research, the research can be started within a year. The first target is androgenetic alopecia, whose mechanism is clear, and the period will be about one and a half years."
Once funded human studies can start within 1 year and then the treatment can go to market after 1 1/2 years. This means it should go to market approx 2 1/2 years after they get the necessary funding. If they got the necessary funding today it should hit the market in 2023.